On November 18, 2025, the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) issued a precedential decision in Duke University, Allergan Sales, LLC v. Sandoz Inc., holding claim 30 of U.S. Patent No. 9,579,270...more
12/11/2025
/ Appeals ,
Biotechnology ,
CAFC ,
Disclosure Requirements ,
Intellectual Property Litigation ,
Life Sciences ,
Patent Invalidity ,
Patent Litigation ,
Patent Prosecution ,
Patent Validity ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Section 112 ,
Written Descriptions